BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 2568015)

  • 1. Treatment of reflux esophagitis with H2-blockers, antacids and prokinetic drugs. An analysis of randomized clinical trials.
    Koelz HR
    Scand J Gastroenterol Suppl; 1989; 156():25-36. PubMed ID: 2568015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic procedures in gastroesophageal reflux disease].
    Tytgat GN
    Z Gastroenterol; 1986 Sep; 24 Suppl 2():40-4. PubMed ID: 2877526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The medical management of reflux esophagitis. Role of antacids and acid inhibition.
    Sontag SJ
    Gastroenterol Clin North Am; 1990 Sep; 19(3):683-712. PubMed ID: 1977703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison between histamine H2-blocker and proton pump inhibitor on the effects of initial treatment in reflux esophagitis].
    Harasawa S
    Nihon Rinsho; 2000 Sep; 58(9):1847-52. PubMed ID: 11004814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug therapy of reflux oesophagitis: an update.
    Tytgat GN
    Scand J Gastroenterol Suppl; 1989; 168():38-49. PubMed ID: 2575792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical studies of sucralfate in reflux esophagitis. The European experience.
    Hameeteman W
    J Clin Gastroenterol; 1991; 13 Suppl 2():S16-20. PubMed ID: 1885899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of gastroesophageal reflux: analysis of randomized double-blind trials].
    Pignon JP; Poynard T; Naveau S; Sebag G; Chaput JC
    Gastroenterol Clin Biol; 1987 Oct; 11(10):668-80. PubMed ID: 2891580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical treatment of gastroesophageal reflux disease: options and priorities.
    Thomson AB
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():14-23. PubMed ID: 1349550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recent topics in the medical treatment of reflux esophagitis].
    Hiraishi H; Shimada T; Terano A
    Nihon Geka Gakkai Zasshi; 1997 Nov; 98(11):942-6. PubMed ID: 9488979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of reflux esophagitis with antacids].
    Weihrauch TR
    Z Gastroenterol; 1983 Mar; 21 Suppl():50-2. PubMed ID: 6344504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H2 antagonists in the treatment of reflux esophagitis: a critical analysis.
    Stalnikowicz-Darvasi R
    Am J Gastroenterol; 1989 Mar; 84(3):245-8. PubMed ID: 2563926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical management of reflux esophagitis.
    Vantrappen G; Janssens J
    Digestion; 1985; 32 Suppl 1():51-8. PubMed ID: 2866136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological management of gastro-oesophageal reflux disease.
    Klinkenberg-Knol EC; Festen HP; Meuwissen SG
    Drugs; 1995 May; 49(5):695-710. PubMed ID: 7601011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upper gastrointestinal motility. Part I--The pathophysiologic approach to the management of reflux esophagitis.
    Holloway RH; Winnan G; McCallum RW
    Am J Gastroenterol; 1981 Sep; 76(3):280-90. PubMed ID: 6119024
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of reflux oesophagitis.
    Wesdorp IC
    Scand J Gastroenterol Suppl; 1982; 79():106-19. PubMed ID: 6131532
    [No Abstract]   [Full Text] [Related]  

  • 17. Gastroesophageal reflux disease: pathophysiology and pharmacology overview.
    Dajani EZ
    J Assoc Acad Minor Phys; 2000; 11(1):7-11. PubMed ID: 10826019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future medical therapy of reflux esophagitis.
    Castell DO
    J Clin Gastroenterol; 1986; 8 Suppl 1():81-5. PubMed ID: 2874169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards an increased efficacy of acid inhibition in the treatment of erosive oesophagitis.
    Lambert R
    J Gastroenterol Hepatol; 1996 Oct; 11(10):897-9. PubMed ID: 8912122
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term management of gastroesophageal reflux disease and its complications.
    Richter JE
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):30S-34S; discussion 34S-35S. PubMed ID: 9127624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.